Skip to main content
. Author manuscript; available in PMC: 2015 May 20.
Published in final edited form as: Bone Marrow Transplant. 2014 May 12;49(9):1139–1145. doi: 10.1038/bmt.2014.89

Table 1.

Current CDC/ACIP Recommendations for Immunization Following BMT

Vaccine Initiate Vaccine Number of Doses Interval Between Doses Evidence Rating
Pneumococcal conjugate (PCV) 3-6 months 3-4 4 weeks B1
PPSV23 After PCV series 1 1 month after PCV series BII
Tetanus, diphtheria, acellular pertussis 6-12 months 3 4 weeks BII
Haemophilus influenza conjugate 6-12 months 3 4 weeks BII
Meningococal conjugate (MCV4) 6-12 months 2 8 weeks BII
IPV 6-12 months 3 4 weeks BII
Hepatitis B 6-12 months 3 4 weeks BII
Hepatitis A 12 months (optional) 2 6 months CIII
Influenza seasonal 4-6 months 1 or 2 Yearly AIII
MMR 24 months, no active GVHD, no immunosuppression 2 4 weeks BII
VZV >24 months, no active GVHD, no immunosuppression (optional) 2 3 months CIII
HPV Age appropriate (optional) 3 Follow CDC CIII

Note: CDC/ACIP = Centers for Disease Control/Advisory Committee on Immunization Practices; PPSV = pneumococcal polysaccharide vaccine; IPV = inactivated polio vaccine; MMR = measles, mumps and rubella; GVHD = graft-versus-host disease; VZV = varicella-zoster virus; HPV = human papilloma virus.